DocDollars

Aurinia Pharma U.S., Inc.

MD · United States · Reporting entity ID 100000961841

Total reported 2019–2025
$16.0M
#373 of 2,960 reporting companies — 0% of all reported industry payments
$7.45M in general payments across 63,942 records, plus $8.53M in research funding across 975 records.

How it breaks down

General payments $7,451,189
Research funding $8,534,947

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.

Summary

Aurinia Pharma U.S., Inc. reported $16.0M to US doctors and teaching hospitals from 2019 to 2025, ranking #373 of 2,960 reporting companies. 53% of that was research funding and 47% general payments such as consulting, speaking, food and travel. 63,942 general payment records and 975 research records were filed.

Common questions about Aurinia Pharma U.S., Inc.

How much has Aurinia Pharma U.S., Inc. paid US doctors?

Aurinia Pharma U.S., Inc. reported $15,986,136 to US physicians and teaching hospitals across the 2019–2025 Open Payments program years: $7,451,189 in general payments, $8,534,947 in research funding.

How does Aurinia Pharma U.S., Inc. rank among drug and device companies?

It ranks #373 of 2,960 reporting entities by total reported value, about 0% of all industry payments in the dataset.

Does a payment from Aurinia Pharma U.S., Inc. mean a doctor did something wrong?

No. Open Payments records transfers of value such as speaking fees, consulting, meals, travel and research funding. The data shows the relationship, not its effect on prescribing or care.